Validity of the Patient-Reported Clinical Global Impression of Change as a Measure of Treatment Response in Men with Premature Ejaculation

被引:28
作者
Althof, Stanley E. [1 ]
Brock, Gerald B. [2 ]
Rosen, Raymond C. [3 ]
Rowland, David L. [4 ]
Aquilina, Joseph W. [5 ]
Rothman, Margaret [6 ]
Tesfaye, Fisseha [5 ]
Bull, Scott [5 ]
机构
[1] Case Western Reserve Univ, Sch Med, Ctr Marital & Sexual Hlth S Florida, W Palm Beach, FL 33401 USA
[2] St Josephs Hlth Ctr, Dept Surg, Div Urol, London, ON, Canada
[3] New England Res Inst, Watertown, MA 02172 USA
[4] Valparaiso Univ, Valparaiso, IN 46383 USA
[5] Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ USA
[6] Johnson & Johnson Pharmaceut Serv LLC, Raritan, NJ USA
基金
美国国家卫生研究院;
关键词
Premature Ejaculation; Sexual Dysfunction; Clinical Global Impression of Change; Treatment; Dapoxetine; OUTCOME MEASURES; BEHAVIOR CHANGES; VALIDATION; QUESTIONNAIRE; SATISFACTION; DEFINITION; DEMENTIA; TRIALS; WOMEN; SCALE;
D O I
10.1111/j.1743-6109.2010.01793.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. The Clinical Global Impression of Change (CGIC) measures have high utility in clinical practice. However, it is unknown whether the CGIC is valued for assessing premature ejaculation (PE) symptoms and/or the relationship between CGIC and other validated PE patient-reported measures. Aim. The study aims to assess the validity of the patient-reported CGIC measure in men with PE and to examine the relationship between CGIC ratings and assessments of control, satisfaction, personal distress, and interpersonal difficulty. Methods. Data from a randomized, double-blind, 24-week phase 3 trial in 1,162 men with PE who received dapoxetine (30 mg or 60 mg) or placebo on demand provided the basis for the analysis. Patients were >= 18 years, in a stable monogamous relationship for >= 6 months, met the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition-Text Revision criteria for PE for >= 6 months, and had an intravaginal ejaculatory latency time (IELT) < 2 minutes in >= 75% of intercourse episodes. Main Outcome Measures. The CGIC asked patients to rate improvement or worsening of their PE compared with the start of the study using a 7-point response scale; other patient-reported measures were control over ejaculation, satisfaction with sexual intercourse, interpersonal difficulty, and personal distress related to ejaculation. Stopwatch-measured IELT was recorded. Associations between CGIC and change in other measures at study end point were assessed. Results. The magnitude of IELT increased for each category of improvement on the CGIC: 1.63, 4.03, and 7.15 minutes for slightly better, better, and much better, respectively. Higher CGIC ratings were correlated with greater improvement in control (r = 0.73), satisfaction (r = 0.62), greater reduction in distress (r = -0.52), and interpersonal difficulty (r = -0.39). Total variance accounted for was 57.4%: control (48.7%), satisfaction (4.5%), IELT (2.8%), and distress (1.15%). Conclusions. The analyses support the validity of the CGIC measure in men with PE. The CGIC can provide clinicians in practice with a valid and brief outcome assessment of their patient's condition. Althof SE, Brock GB, Rosen RC, Rowland DL, Aquilina JW, Rothman M, Tesfaye F, and Bull S. Validity of the patient-reported clinical global impression of change as a measure of treatment response in men with premature ejaculation. J Sex Med 2010;7:2243-2252.
引用
收藏
页码:2243 / 2252
页数:10
相关论文
共 39 条
[1]   Psychometric validation of a sexual quality of life questionnaire for use in men with premature ejaculation or erectile dysfunction [J].
Abraham, Lucy ;
Psychol, C. ;
Symonds, Tara ;
Morris, Mark F. .
JOURNAL OF SEXUAL MEDICINE, 2008, 5 (03) :595-601
[2]   Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation [J].
Althof, S ;
Rosen, R ;
Symonds, T ;
Mundayat, R ;
May, K ;
Abraham, L .
JOURNAL OF SEXUAL MEDICINE, 2006, 3 (03) :465-475
[3]   Prevalence, characteristics and implications of premature ejaculation/rapid ejaculation [J].
Althof, SE .
JOURNAL OF UROLOGY, 2006, 175 (03) :842-848
[4]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[5]  
Beck A.T., 1996, PSYCHOL ASSESSMENT
[6]   Dapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries [J].
Buvat, Jacques ;
Tesfaye, Fisseha ;
Rothman, Margaret ;
Rivas, David A. ;
Giuliano, Francois .
EUROPEAN UROLOGY, 2009, 55 (04) :957-968
[7]   Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction [J].
Cappelleri, JC ;
Althof, SE ;
Siegel, RL ;
Shpilsky, A ;
Bell, SS ;
Duttagupta, S .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2004, 16 (01) :30-38
[8]  
Demyttenaere Koen, 2009, Prim Care Companion J Clin Psychiatry, V11, P8
[9]   Gabapentin's effects on hot flashes in postmenopausal women: A randomized controlled trial [J].
Guttuso, T ;
Kurlan, R ;
McDermott, MP ;
Kieburtz, K .
OBSTETRICS AND GYNECOLOGY, 2003, 101 (02) :337-345
[10]   The Clinical Global Impression-Schizophrenia scale:: a simple instrument to measure the diversity of symptoms present in schizophrenia [J].
Haro, JM ;
Kamath, SA ;
Ochoa, S ;
Novick, D ;
Rele, K ;
Fargas, A ;
Rodríguez, MJ ;
Rele, R ;
Orta, J ;
Kharbeng, A ;
Araya, S ;
Gervin, M ;
Alonso, J ;
Mavreas, V ;
Lavrentzou, E ;
Liontos, N ;
Gregor, K ;
Jones, PB .
ACTA PSYCHIATRICA SCANDINAVICA, 2003, 107 :16-23